Receptor Occupancy of ITI-007 Using Positron Emission Tomography (PET) in Patients With Stable Schizophrenia
| Status: | Completed |
|---|---|
| Conditions: | Schizophrenia |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - 60 |
| Updated: | 3/11/2017 |
| Start Date: | October 2014 |
| End Date: | September 2015 |
An Open-Label Positron Emission Tomography (PET) Study to Demonstrate Receptor Occupancy, Safety, Tolerability and Pharmacokinetics of ITI-007 in Stable Schizophrenia Patients
The purpose of this study is to determine the relationship between ITI-007 dose, plasma
levels and brain receptor occupancy in patients with stable schizophrenia.
levels and brain receptor occupancy in patients with stable schizophrenia.
Inclusion Criteria:
- Patients with schizophrenia who are drug-free with regard to their antipsychotic
medication
- In clinical remission and free from acute exacerbation of their psychosis
- In good health
Exclusion Criteria:
- Clinically significant medical conditions considered inappropriate for trial
participation
We found this trial at
1
site
Click here to add this to my saved trials
